Category: Economy

Economy TNM WRK

EQT Mid Market acquires compliance and integrity service provider Dataflow

admin

HONG KONG, July 25, 2014 /PRNewswire/ — The EQT Mid Market fund (“EQT Mid Market”) yesterday acquired Dataflow Verification Services Limited (“Dataflow” or the “Company”) from the founders. Dataflow is a leading provider of immigration compliance and credential verification service to governments, government-sanctioned authorities and private institutions.

Dataflow was founded in 2006 and is headquartered in Hong Kong. The Company has operations in the Gulf Cooperation Council (GCC) region, India, Jordan, Singapore and Malaysia, and has a team of around 450 experts and researchers. Dataflow helps clients to conduct primary source verification (PSV) on credentials of highly skilled professionals, for example doctors, nurses or engineers, as part of mandatory immigration and credentialing programs, and processes more than 200,000 applications annually from 168 countries. Dataflow has relationships with over 25,000 issuing authorities such as schools, universities and other professional bodies around the world.

The global demand for highly skilled specialists across industries and sectors has led to a rise in the movement of labor throughout the GCC region as well as between other countries in the world. The movement of skilled and highly educated labor has increased the demands for PSV services in order to avoid recruitments based on fraudulent credentials.

Following the growing requirements for PSV services, Dataflow has established a leading market position in the GCC region with high customer retention. Dataflow offers its clients tailored PSV services with high integrity and quality which are scalable, cost efficient and provide a quick turnaround time. The globalization and the continued movement of labor is expected to offer substantial growth opportunities in both existing and new clients and countries.

Mr. Douglas Nairne, Co-founder and Chief Executive Officer of Dataflow, said: “EQT Mid Market is an ideal partner as Dataflow plans to grow and expand further. EQT has an industrial and hands-on approach and we share the vision of creating value for our stakeholders and the communities we protect. We are excited to work with EQT and their network of Industrial Advisors. Together, we will continue to deliver superior services to our clients and serve and protect the communities they represent.”

“We are impressed by the high quality of Dataflow’s compliance and integrity service offering. The management team has achieved to position Dataflow as a true leader and EQT looks forward to deploying its global resources to support its growth and development strategy further,” says Tak Wai CHUNG, Partner at EQT Partners, Investment Advisor to EQT Mid Market.

The parties have agreed to not disclose the transaction value.

Contacts:

Tak Wai CHUNG, Partner at EQT Partners, Investment Advisor to EQT Mid Market, +852 2801 6823

Johan Hahnel, EQT Mid Market Spokesperson, +46 706 05 63 34

Economy

OANDA Revolutionizes Mobile Trading with fxTrade Mobile 4.0

admin

SINGAPORE, July 24, 2014 /PRNewswire/ — OANDA, a global provider of innovative foreign exchange and CFD trading services, is pleased to announce the first phase of its next-generation fxTrade Mobile trading application. Beginning with new, industry-first features to its proprietary application for the Apple iPad, OANDA is moving away from a “one-size-fits-all” approach to mobile trading.

Available now for free download in the App Store, OANDA’s fxTrade Mobile 4.0 for iPad features unlimited charts, the ability for individual traders to arrange charts however they wish, and the ability to view charts in full-screen mode.

“We’re redefining the way investors are trading on mobile, moving toward customization based on each trader’s experience and trading strategies. We started with the iPad, as it’s the tablet with the highest market penetration and the most screen real estate,” said Reuben Piryatinsky, Mobile Product Manager, OANDA Corporation. “We’re confident this new approach to trading will help us maintain our industry-leading position in the mobile space.”

OANDA’s mobile team will continue to release more customizable features, specific to individual trading styles, in the coming months. New elements in fxTrade Mobile will add to its existing advanced charting functionality with multiple chart types and more than 40 technical analysis indicators, overlays, and drawing capabilities, streaming news feeds, and push notifications for limit orders, stop-loss and take-profit actions, margin notifications, and price alerts.

“We were the first broker to release a tablet trading app and so much has changed in four years. At the time, our goal was to match the desktop feature set but we’ve already eclipsed that and have more rich features available for mobile,” said Trevor Young, Vice President of Product Management, OANDA Corporation. “We are also seeing increased volumes coming through mobile: in 2010, it accounted for two or three percent of total volume and today it is closer to 20 percent.”

Today, more than 50 percent of OANDA’s clients log-in to their accounts daily via fxTrade Mobile. Like OANDA’s MetaTrader 4 mobile applications for iPhone and Android smartphones and tablets, and OANDA’s Currency Converter for iPhone, iPad, iPod touch, and Android devices, fxTrade Mobile is available to download for free.

For more information, please visit http://www.oanda.sg. You can follow OANDA on Twitter, Facebook, or YouTube.

For more information, please contact:

The Hoffman Agency for OANDA Asia Pacific
Adele Soh
Direct: +65-6361-0250
Email: OANDASG@hoffman.com  
www.hoffman.com

CSE Economy

Tablet Shipments Rose by 6 Percent Year-on-Year in Q2 2014 says Strategy Analytics

admin

BOSTON, July 24, 2014 /PRNewswire/ — According to the latest research from Strategy Analytics, global tablet shipments reached 52.9 million units in the second quarter of 2014. Android secured a robust 70 percent global share, while Apple iPad shipments were below expectations and iOS fell to 25 percent. Windows secured a 5 percent global share.

Logo – http://photos.prnewswire.com/prnh/20130207/NE56457LOGO-b

Peter King, Director of Tablet research at Strategy Analytics, said, “Global Tablet shipments reached 52.9 million units in Q2 2014, up 6 percent from 50.0 million in Q2 2013. Android consolidation continued as it was the chosen OS for seven out of ten Tablets shipped in the market. Android vendors shipped 36.8 million units between them worldwide in Q2 2014, up 11% from 33.2 million a year earlier. Android is continuing to make steady progress due to the wide range of vendors and wide range of screen sizes and price-points.” King added, “Apple iOS shipments (sell-in) were 13.3 million iPads in Q2 2014 leaving it with a 25% share of the global Tablet market. The 13.3 million shipments represented decline of 9% annually and 19% sequentially; it is nine quarters since Apple produced such a low Tablet shipment figure.”

Exhibit 1: Global Tablet Operating System Shipments and Market Share in Q1 2014 (preliminary)

Global Tablet OS Shipments (Millions of Units)

Q2’13

Q2’14

Apple iOS

14.6

13.3

Android

33.2

36.8

Windows

2.1

2.7

Others

0.1

0

Total

50

52.9

Global Tablet OS Marketshare %

Q2’13

Q2’14

Apple iOS

29%

25%

Android

66%

70%

Windows

4%

5%

Others

0%

0%

Total

100%

100%

Growth Year-on-Year %

39%

6%

Source: Strategy Analytics Tablets & Touchscreen Service

Shipments refer to sell-in. Numbers are rounded. The definition of Tablet does not include e-book readers or convertible PCs

Click here for the full report:
https://www.strategyanalytics.com/default.aspx?mod=reportabstractviewer&a0=9886

Published by the Strategy Analytics Tablet & Touchscreen Strategies (TTS) service.

Economy LIC

China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy

admin

HONG KONG, July 23, 2014 /PRNewswire-FirstCall/ — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, and Cordlife Group Limited (“Cordlife“), a multi-product healthcare company catering to the mother and child segment, today announced that the two companies have joined forces in assisting patients across the PRC, Singapore, Hong Kong, Indonesia, India, the Philippines and Malaysia to identify suitable cord blood matching units for stem cell therapy.

Under the Memorandum of Understanding signed between the two companies, Cordlife, on behalf of its patients who are in need of cord blood stem cell therapy, can facilitate the process by providing relevant information to CCBC, who will then perform searches for possible matching units among its donated cord blood samples in the PRC. For patients who reside in the PRC, CCBC may seek Cordlife’s assistance or contacts to source possible cord blood unit matches in the relevant public cord blood registries in the regions where Cordlife operates, which include Hong Kong, Singapore, India, Indonesia, the Philippines, and Malaysia.

Mr. KAM Yuen, Chairman of China Cord Blood Corporation commented, “Both CCBC and Cordlife share a common vision which is to enhance people’s lives through the widening of umbilical cord blood stem cells application services. Our proposed collaboration will assist families in the PRC and other parts of Asia who face difficulties obtaining a matching cord blood unit to widen their search, resulting in the increased likelihood of receiving treatment.”

Mr. Jeremy YEE, Executive Director and Chief Executive Officer of Cordlife said, “We are glad to collaborate with CCBC in a joint effort to make cord blood stem cell therapy more widely available to our patients, particularly those who have difficulty finding a matching cord blood unit. Our two companies share a common goal of providing the best services, saving lives and improving quality of life for people in the Asia region.”

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.

About Cordlife Group Limited (Bloomberg stock code: CLGL SP)

Incorporated in May 2001, Cordlife Group Limited (“Cordlife”) is a multi-product healthcare company catering to the mother and child segment and a leading cord blood and umbilical cord lining banking services provider. Today, Cordlife operates the largest[1] private cord blood banks in Singapore, the Philippines and Indonesia; and is amongst the top three market leaders in Hong Kong and India. Cordlife also holds 10% and 31.81% stakes in China Cord Blood Corporation and StemLife Berhad respectively, both of which are their countries’ largest cord blood bank operators. For more information, please visit www.cordlife.com.

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, performance and results of operations, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the U.S. Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com

ICR, Inc.
Mr. Bill Zima
Tel: (+86) 10-6583-7511 (China) or (+1) 646-405-5185 (U.S.)
Email: william.zima@icrinc.com

[1]

Source : Deloitte & Touche Financial Advisory Services Limited report, 10 April 2013